MSO Ascend Wellness Holdings claimed MSO MedMen had challenged the authority of New York regulators. The accusation comes after MedMen announced, earlier this week, that it would terminate a deal to be sell more than 86% of its New York...
This content is FREE for registered users.
To view this content you need to register as a Weedweek member.
If you are already a member please login below.
or
Share:
pro
DCC’s interstate trade memo: An analysis
This week the California Department of Cannabis Control (DCC) sent a memo to California Attorney General Rob Bonta requesting a legal opinion on whether interstate trade poses a "significant risk...
pro
SCOOP: Kingroll responds to potency fraud suit
In September, WeedWeek published a story which found samples from seven out of seven prominent California pre-roll brands contained less THC than stated on their label. Since then, at least...
pro
Seven ways to see a debt crisis
No one denies that the California cannabiz faces a debt crisis. As insiders described recently to Green Market Report, years of unpaid bills and taxes are building to a “mass...
